These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15693445)

  • 1. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
    Murai Z; Baran B; Tolna J; Szily E; Gazdag G
    Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropsychiatric symptoms in preventive antimalarial treatment with mefloquine: apropos of 2 cases].
    Lebain P; Juliard C; Davy JP; Dollfus S
    Encephale; 2000; 26(4):67-70. PubMed ID: 11064842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report.
    Tran TM; Browning J; Dell ML
    Malar J; 2006 Aug; 5():74. PubMed ID: 16925829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychopathological phenomena in long-term follow-up of acute psychosis after preventive mefloquinine (Lariam) administration].
    Meszaros K; Kasper S
    Nervenarzt; 1996 May; 67(5):404-6. PubMed ID: 9005352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mefloquine-induced pneumonitis.
    Soentjens P; Delanote M; Van Gompel A
    J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
    Minei-Rachmilewitz T
    Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mood disorder after malaria prophylaxis with mefloquine (two case reports)].
    Oueriagli Nabih F; Touhami M; Laffinti A; Abilkacem L
    Encephale; 2011 Oct; 37(5):393-6. PubMed ID: 22032283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
    Fuller SJ; Naraqi S; Gilessi G
    P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric events during prophylactic use of mefloquine before travelling.
    van Riemsdijk MM; Ditters JM; Sturkenboom MC; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
    Eur J Clin Pharmacol; 2002 Sep; 58(6):441-5. PubMed ID: 12242605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
    Bygbjerg IC; Rønn AM
    Ugeskr Laeger; 1999 Mar; 161(10):1422-3. PubMed ID: 10085752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA; Bosje T; Luinstra-Passchier MJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine.
    Clattenburg RN; Donnelly CL
    J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B; Péguet C; Nevez G
    Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Many travellers suffer of side-effects of malaria prophylaxis].
    Rietz G; Petersson H; Odenholt I
    Lakartidningen; 2002 Jun; 99(26-27):2939-44. PubMed ID: 12170684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychotic episode caused by prevention of malaria with mefloquine. A case report].
    Folkerts H; Kuhs H
    Nervenarzt; 1992 May; 63(5):300-2. PubMed ID: 1603191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions.
    Bem JL; Kerr L; Stuerchler D
    J Trop Med Hyg; 1992 Jun; 95(3):167-79. PubMed ID: 1597872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood mefloquine-induced mania and psychosis: a case report.
    Thapa R; Biswas B
    J Child Neurol; 2009 Aug; 24(8):1008-9. PubMed ID: 19295181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A severe adverse reaction to mefloquine and chloroquine prophylaxis.
    Lysack JT; Lysack CL; Kvern BL
    Aust Fam Physician; 1998 Dec; 27(12):1119-20. PubMed ID: 9919736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine.
    Hennequin C; Bourée P; Bazin N; Bisaro F; Feline A
    Arch Intern Med; 1994 Oct; 154(20):2360-2. PubMed ID: 7944858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials.
    Meier CR; Wilcock K; Jick SS
    Drug Saf; 2004; 27(3):203-13. PubMed ID: 14756582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.